About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Boston | 392 Studies

Clinical Trials Ovarian CancerBoston

Ovarian Cancer Clinical Trials in Boston

Find 392 clinical trials for ovarian cancer near Boston, Massachusetts. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 392 trials

RecruitingPhase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsPhase 1/2, open-label study of ETX-636 in participants with advanced solid tumorsNCT06993844·Newport Beach, California and 14 others UnknownHORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday LifeThe purpose of this study is to invite all people diagnosed with cancer who meet the eligibility criteria to complete questionnaires before their treatment begins and at regular…NCT03000192·Aberystwyth and 110 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid TumorsThis is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti-lymphocyte activation gene-3 (LAG-3) antibody TSR-033 alone, in combination with the anti-PD-1…NCT03250832·Los Angeles, California and 11 others

Active not recruitingLetrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary…NCT04095364·Anchorage, Alaska and 908 others

CompletedA Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentThe study seeks to assess the safety, pharmacodynamics, pharmacokinetics and efficacy of belinostat (PXD101) administered in combination with carboplatin or paclitaxel or both in…NCT00421889·Newport Beach, California and 10 others

CompletedA Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy…NCT03849469·Encinitas, California and 27 others

RecruitingA Study of Opportunistic Salpingectomy to Prevent Ovarian CancerThe purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video.NCT06312124·Baltimore, Maryland and 9 others

CompletedS0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00043082·Mobile, Alabama and 90 others

Active not recruitingA Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsThe purpose of this study is to find out whether the study drug, LY4101174, is safe, tolerable and effective in participants with select advanced or metastatic solid tumors.NCT06238479·Orlando, Florida and 27 others

UnknownDOD Long-Term Survivors of Ovarian Cancer: Stages III and IV serum ovarian cancer are the most lethal of all gynecologic cancers; however, some advanced-stage ovarian cancer patients are long-term survivors.NCT02321735·Boston, Massachusetts

TerminatedStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsThis study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene…NCT04383210·Birmingham, Alabama and 41 others

CompletedA Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian CancerThe purpose of this study is to evaluate the effect of BSI-201 on the objective response rate in platinum-resistant recurrent ovarian cancer patients receiving gemcitabine and…NCT01033292·Boston, Massachusetts

CompletedPhase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian CancerTo assess the incidence of drug-related adverse events of Grade 3 or higher and the overall response associated with ipilimumab treatmentNCT01611558·New Haven, Connecticut and 16 others

UnknownSymptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerThis randomized clinical trial is studying two different symptom management programs to see how well they work compared with usual care in patients with recurrent or persistent…NCT00958698·Phoenix, Arizona and 143 others

RecruitingComprehensive Outcomes for After Cancer HealthThis study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have completed primary…NCT05349227·Gainesville, Florida and 6 others

RecruitingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationThe purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors.NCT05059444·Birmingham, Alabama and 56 others

CompletedEfficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian CancerThis is an open label, single arm, multi-center study to assess the efficacy and safety of the combination of cediranib and olaparib tablets in platinum-resistant relapsed high…NCT02889900·Mobile, Alabama and 24 others

TerminatedA Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid TumorsThis was a multi-center, open-label, phase Ib/II study.NCT01708161·Los Angeles, California and 9 others

TerminatedPROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid TumorsThe purpose of this first-in-human study of CX-2009 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-2009 in…NCT03149549·Los Angeles, California and 25 others

CompletedA Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid TumorsTo determine the maximum tolerated dose or optimal biological dose, and the safety profile of MEDI3617 when given as a single-agent or in combination with other chemotherapeutic…NCT01248949·Los Angeles, California and 9 others

Page 1 of 20Next

Other Conditions in Boston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia